Global Pericardial Patches Market
Pericardial Patches Market size was valued at USD 336.8 million in 2024 and is projected to reach a valuation of USD 777.9 million by the end of 2037, rising at a CAGR of 6.6% during the forecast period, i.e., 2025-2037. In 2025, the industry size of pericardial patches is assessed at USD 358.8 million.
The pericardial patches market is anticipated to rise at a steady pace due to advances in cardiovascular surgery and the rise in the prevalence of heart diseases. These patches, applied to various surgical techniques, offer superior biocompatibility and flexibility for better performance in patient outcomes. Key players in the market have been introducing new, innovative products targeting different surgical needs. In April 2023, Aziyo Biologics signed a distribution agreement with LeMaitre Vascular to distribute various products, such as ProxiCor PC, to further strengthen its cardiovascular segment. This reflects the growing trend of company collaborations in developing superior product offerings and gaining broader pericardial patches market access.
The demand for pericardial patches is driven by integrating advanced technologies, including bioengineering and synthetic materials. Furthermore, government regulatory authorities also impose strict quality standards to ensure safety and effectiveness, which aligns with growing consumer expectations for sophisticated medical solutions. For instance, in the U.S., The FDA has imposed new guidelines, which include stringent tests for the biocompatibility and performance of medical devices. This ascertains that pericardial patches meet high standards of safety before they reach the market.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.6% |
|
Base Year Market Size (2024) |
USD 336.8 million |
|
Forecast Year Market Size (2037) |
USD 777.9 million |
|
Regional Scope |
|
Type (Synthetic Pericardial Patches, Biological Pericardial Patches)
In pericardial patches market, biological pericardial patches segment is projected to dominate revenue share of around 88% by the end of 2037. These patches are preferred owing to their superior biocompatibility with low chances of immune rejection compared to the synthetic alternative. This wide use in cardiac and vascular surgery underlines their clinical effectiveness. In January 2020, Tendyne marked a milestone by completing the first commercial implantation of its Transcatheter Mitral Valve System using a biological patch, furthering minimally invasive treatments. The preference for these products points toward their important position in modern surgical applications.
Source (Bovine, Porcine, Equine, Others)
By 2037, bovine segment is set to dominate pericardial patches market share of over 40.4%. The growth of the segment can be attributed to the performance that bovine materials display while being used in pericardial applications, such as cardiovascular repairs. Furthermore, with enhancements in processing techniques, durability and compatibility also improve, making them adaptable for medical use. Their application in a variety of surgical procedures underlines their growing relevance. The growth in this segment reflects the demand for dependable and biocompatible materials in healthcare.
Our in-depth analysis of the pericardial patches market includes the following segments
|
Type |
|
|
Source |
|
|
Application |
|
|
End user |
|
North America Market Analysis
By the end of 2037, North America pericardial patches market is set to hold over 37.8% revenue share. This leadership is driven by the region's strong healthcare infrastructure and significant investment in cardiovascular research and treatment advancements. A key development highlighting this focus is the acquisition by Baxter International Inc. of the PerClot Polysaccharide Hemostatic System from CryoLife, Inc., in July 2021, for as much as USD 60.8 million, including an up-front payment of USD 25 million. The transaction marked Baxter's strategic entry into the hemostatic powder segment and strengthened its portfolio considerably with active and passive hemostatic solutions.
The U.S. is predicted to dominate the pericardial patches market in North America. A strong network of cardiovascular centers with a high level of specialization and a high degree of adoption of advanced medical technologies drives the demand for these products. The regulatory environment, though strict, allows for innovation with well-defined pathways for product approvals, as evidenced by the rapid adoption of novel solutions such as the Integrity Implant System. This focus on addressing complex cardiovascular conditions ensures steady pericardial patches market growth in the country.
Canada also accounts for a major share of the North America pericardial patches market due to its advanced healthcare system and wide accessibility of surgical treatments. The country focuses on collaboration between research institutions and medical device manufacturers, thus encouraging innovation in pericardial patch technology. Having nearly half the population size compared to the United States, the total expenditures spent on healthcare by Canada were estimated at USD 9,054 per capita, growing 5.7 percent from the previous year of estimation, which boosts its steady contribution towards regional market growth.
Asia Pacific Market Statistics
Asia Pacific pericardial patches market is expected to showcase growth rate of around 7.2% between 2024 and 2037 due to enhanced access to healthcare and increasing awareness about cardiovascular treatments. Large populations, especially in countries like India and China, along with a rise in the prevalence of heart-related conditions, create significant demand for sophisticated medical solutions. In addition, the initiatives taken by the government for better healthcare infrastructure and promotion of advanced surgical technologies further complement market growth. Thus, all these factors have put the region as one of the major contributors toward the global growth of the pericardial patches market.
India is also emerging as a significant market in Asia Pacific due to the rising burden of cardiovascular diseases and improving healthcare infrastructure. The government's focus on accessing advanced medical technologies further boosts the adoption of pericardial patches. This is evident from the fact that nearly 24.8% of all deaths in India are related to cardiovascular diseases, creating an immediate need for innovative medical solutions such as pericardial patches.
China is a significant growth influencer in the Asia Pacific for pericardial patches, impelled by the rapid strengthening of healthcare infrastructure and considerable patient pools. Central government encouragement has been done to increase medical device manufacturing, thereby promoting improved cardiovascular product development. At present, nearly 106 million patients in the country have cardiovascular disease, thus necessitating effective treatments of surgery. This underlines the critical use of effective surgical solutions and positions China as a significant facilitator in regional market spread.
The pericardial patches market is highly competitive and consists of leading players such as Abbott Laboratories, Baxter International, Collagen Solutions LLC, Edwards Lifesciences Corporation, and LeMaitre Vascular, Inc. These companies are investing heavily in research and development to develop next-generation products for emerging needs in surgery. Strategic partnerships and acquisitions are further enhancing their market reach and strengthening their global presence. This is clearly seen within the focus of their product pipelines, aiming to address the complexities in cardiovascular repairs. These companies continue leveraging the latest technology and clinical expertise to compete. When interacting with each other, these aspects make the pericardial patches market environment dynamic and geared toward growth.
In January 2024, Neovasc announced positive results from its pivotal trial of the Tiara bioengineered patch. The Tiara patch, designed for precise bioengineering, represents a breakthrough in tackling complex cardiac conditions. This is a sign that the companies in the industry are committed to innovation and underlines the focus of the entire industry on meeting critical needs in cardiovascular care. These results pave the way for potential regulatory approval, reflecting the competitive drive to bring advanced solutions to the market. Furthermore, such developments illustrate the high stakes and rapid pace of innovation characterizing the pericardial patches industry.
Here are some leading companies in the pericardial patches market
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?